Sunday, April 12, 2020 6:28:58 PM
You triple down on the nitroglycerin today? Really bringing the heat STRONG!
Here's what I sent out today to approximately fifteen reporters at LA Times & Seattle Times. Who knows, it's worth a shot , and certainly the story has a Washington & California flavor( Patterson & Lalezari )to it. May not be everyones idea of journalism, but if you want/can copy/paste - or send me contacts & I'll forward the message - Best to all--
Sharing that Washington based biotech, Cytodyn,Inc, and it’s novel monoclonal antibody Leronlimab are now saving the lives of critically ill Coronavirus patients in ICU’s across America. FDA approved for Coronavirus use, first patients were treated in March at Montefiore-Einstein hospital under the guidance of Dr. Harish Seethamraju ( A true hero in fight against the virus).
After seeing astonishing early patient response ( 100% of patients benefitted) often in 1 to 7 days, the FDA quickly granted expanded access being very familiar with Leronlimab’s impressive safety/efficacy having data on 850+ HIV, Cancer & GVHD clinical trial patients. As with other indications, Leronlimab has consistently shown superb results slowing/stopping Coronavirus spread with NO side effects. Safe & tolerable - just ONE 700mg shot per week.
Doctors are clamoring for the drug, as example, Cytodyn, Inc partnered with Novant Health care systems bringing treatment to hospitals in the Carolinas, Georgia & Virginia. Further, the FDA quickly blessed TWO Ph II/III Coronavirus trials along with continuing original EIND protocol.This is the ONLY DRUG making a meaningful life saving difference in ICU's.
Leronlimab is the FUTURE of HIV, certain cancers, GVHD & now Coronavirus. Attached within is a video clip from Seal Beach California woman saved by Leronlimab as well as many of the recent press releases posted at company website. Cytodyn management & lead scientists (Dr. Nadar Pourhassan, Dr. Jacob Lalezari & Dr. Bruce Patterson) have moved with lightening speed to work with the FDA to get it’s life saving drug into the hands of doctors, saving countless lives and certainly is worthy of recognition as being on the frontlines of the fight against Coronavirus.
www.cytodyn.com CEO Dr. Nadar Pourhassan. npourhassan@cytodyn.com.
https://losangeles.cbslocal.com/2020/04/10/coronavirus-survivor-leronlimab/
https://content.equisolve.net/_db373f8119150c85817ed8f616297d92/cytodyn/news/2020-04-09_Blood_Samples_at_Day_0_3_and_7_for_Severely_Ill_413.pdf
https://content.equisolve.net/_db373f8119150c85817ed8f616297d92/cytodyn/news/2020-04-07_Novant_Health_Initiates_Phase_2_COVID_19_Trial_411.pdf
https://www.montefiore.org/body_mobile.cfm?id=1743&action=detail&ref=18574
https://content.equisolve.net/_db373f8119150c85817ed8f616297d92/cytodyn/news/2020-04-09_Severely_Ill_COVID_19_Patient_at_Leading_Southern__412.pdf
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM